Participants 160 229 5
intravenously in patients with unresectable pancreatic adenocarcinoma
Participants 686 876 7
Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas were randomised to receive KAb 201 via either the intra-arterial or intravenous delivery route
Participants 1026 1088 7
Between February 2003 and July 2005, 25 patients were enrolled
Participants 1090 1179 3
Nineteen patients were randomised, 9 to the intravenous and 10 to the intra-arterial arms
